💸Cancer-related GoFundMe #crowdfunding raised $506M in 16 months in the US, which is ~ 1/3 of the total requested & a fraction of pts total out-of-pocket costs. Use of crowdfunding underscores substantial unmet financial needs among US cancer survivors. jnccn.org/view/journal...

Excited to share our new review on Imaging in Neuro-oncology We outline core & advanced MRI techniques, amino acid PET, RANO criteria, and where radiomics & AI are taking the field. Imaging remains central to precision neuro-oncology @ecoffeemd.bsky.social doi.org/10.1055/a-27...

🎙️Before We Go @podcastnation.bsky.social Mark Cuban and Dr. Fumiko Chino Try to F-Up Healthcare   Dr Shoshana hosts an incredible convo w @mcuban.bsky.social ("He had a good life & he f-up’d healthcare") & myself about how to fix our broken system from w/in or burn it down from the outside. 🔥

ICYMI - Our @NEJM Perspective argues that federal restrictions on Emergency Medicaid could restrict care for immigrants and strain safety-net hospitals. Preserving state flexibility is both fiscally smart and morally necessary www.nejm.org/doi/full/10....

Financial toxicity screening helps identify patients in need—but most still struggle to get help. In our new study, 81% of patients screening positive didn’t receive an intervention, underscoring the need for stronger infrastructure & policy reform. ascopubs.org/doi/full/10....

Financial toxicity screening helps identify patients in need—but most still struggle to get help. In our new study, 81% of patients screening positive didn’t receive an intervention, underscoring the need for stronger infrastructure & policy reform. ascopubs.org/doi/full/10....

Challenges in Delivering Financial Assistance After Positive Financial Toxicity Screens - Fumiko Ladd Chino @fumikochino.bsky.social @chaewonhwangmd.bsky.social @jbudhu.bsky.social @bthomphd.bsky.social oncodaily.com/voices/fumik... #OncoDaily #Oncology #Cancer #Health #Medicine #MedOnc #MedNews

Our @nejm.org perspective is now available - in it, we argue for the need for state flexibility in Emergency Medicaid. It's only a tiny percentage of overall Medicaid spending, is cost-effective, and helps sustain our safety net hospitals. www.nejm.org/doi/full/10....

Emergency Medicaid accounts for <1% of Medicaid spending — yet saves lives & money. Restricting it ignores evidence, burdens states, and harms communities. Our latest via @nejm.org Emergency Medicaid at Risk - Preserving State Authority and Access to Care www.nejm.org/doi/full/10.... 🧵1/6

Emergency Medicaid accounts for <1% of Medicaid spending — yet saves lives & money. Restricting it ignores evidence, burdens states, and harms communities. Our latest via @nejm.org Emergency Medicaid at Risk - Preserving State Authority and Access to Care www.nejm.org/doi/full/10.... 🧵1/6

For decades, the narrowly defined Emergency Medicaid (EM) program has reimbursed hospitals for emergency care provided to uninsured, low-income immigrants. In @nejm.org, we write in defense of state flexibilities in EM, which seem at risk: www.nejm.org/doi/full/10.... cc @chpc-cornell.bsky.social

Our new NEJM commentary argues on the need to preserve state autonomy for Emergency Medicaid, and the critical role EM plays in supporting undocumented immigrants and safety net hospitals www.nejm.org/doi/full/10....

Honored to share that I am a American Medical Women’s Association (AMWA) Inspire Award Recipient! Congratulations to this incredible group of physicians! www.amwa-doc.org/news/announc...

Disparities in neurology are not random. They stem from upstream determinants (classism, poverty, environment) & downstream barriers (access, treatment gaps). Our @natrevneurol.nature.com review maps these drivers & highlights interventions to advance equity. rdcu.be/eFqGX

Disparities in neurology are not random. They stem from upstream determinants (classism, poverty, environment) & downstream barriers (access, treatment gaps). Our @natrevneurol.nature.com review maps these drivers & highlights interventions to advance equity. rdcu.be/eFqGX

Nearly 1 in 3 neurologists in the US trained abroad. Immigrant neurologists fill critical gaps in underserved communities but face visa barriers & uncertainty. Supporting them is essential for equitable neurologic care. My latest in @greenjournal.bsky.social www.neurology.org/doi/10.1212/...

Immigrant neurologists face uncertainty about visas, careers, and families. They care for some of our most vulnerable patients. Supporting them is both a moral obligation and essential to the future of our field. My viewpoint in @greenjournal.bsky.social www.neurology.org/doi/10.1212/...

Immigrant neurologists face uncertainty about visas, careers, and families. They care for some of our most vulnerable patients. Supporting them is both a moral obligation and essential to the future of our field. My viewpoint in @greenjournal.bsky.social www.neurology.org/doi/10.1212/...

Father’s Day marked 17 years since my brother died—sedated, shackled, and alone in a hospital bed. His death wasn’t inevitable. It was systemic. I share his story, and what it taught me about health, justice, and memory. Thank you @nejm.org www.nejm.org/doi/full/10....

Father’s Day marked 17 years since my brother died—sedated, shackled, and alone in a hospital bed. His death wasn’t inevitable. It was systemic. I share his story, and what it taught me about health, justice, and memory. Thank you @nejm.org www.nejm.org/doi/full/10....

A bit late in sharing, but proud of this piece published in @pedneurojournal.bsky.social. As DEI efforts face backlash, we argue why neurologists must stay committed to equity for the health of our profession and our patients. www.pedneur.com/article/S088... @dianacejasmd.bsky.social

Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad Scope and Implementation - A Progress Report. academic.oup.com/neuro-oncolo...

So excited for #AANAM 2025! Join us for a session on Neurologic Consultations in Cancer Patients on Sunday, 4/6/25 at 3:30pm!

So excited to see this come out! In this article, we go over how drugs are approved, financial toxicity and the impact on our patients, and the financial implications of vorasidenib Financial challenges of being on long-term, high-cost medications academic.oup.com/nop/advance-...

Had such an amazing time at #SNO2024 @neuroonc.bsky.social Wonderful to see updates in CNS tumor treatment, quality of life interventions, and colleagues from around the world!

Final sessions at #SNO2024! 🌟 to dive into neuro-oncology’s latest breakthroughs and future directions. 🗓️ Sunday, Nov 24 ⏰ 10:15 AM - 11:30 AM 🧠 Emerging therapies in glioblastoma 🔬 Advances in immuno-oncology 💡 Collaborative approaches Let’s finish strong and inspire the future of neuro-oncology!